iTonic Holdings Ltd

iTonic Holdings Ltd(ITOC)の株式分析

$1.645

-0.053 (-3.24%)終値時点

Loading chart…
高値
1.720
始値
1.630
出来高加重平均価格
1.67
出来高
6.05K
時価総額
—
安値
1.630
売買代金
10.07K
EV/EBITDA(TTM)
0.00

iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.

www.ftzy.com.cn/ir

AI分析 of iTonic Holdings Ltd (ITOC)

売り

iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.

バリュエーション指標

iTonic Holdings Ltd(ITOC)の現在の予想PERは0.00で、5年平均はです。

予想PER

5年平均 P/E
現在のP/E
0.00

予想EV/EBITDA

5年平均 EV/EBITDA
現在のEV/EBITDA
0.00

予想PSR

5年平均 P/S
現在のP/S
0.00

ITOC のよくある質問 — Alphio AI が回答

iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others. It operates in the Healthcare sector.

iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める